DE3426564A1 - Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind - Google Patents

Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind

Info

Publication number
DE3426564A1
DE3426564A1 DE3426564A DE3426564A DE3426564A1 DE 3426564 A1 DE3426564 A1 DE 3426564A1 DE 3426564 A DE3426564 A DE 3426564A DE 3426564 A DE3426564 A DE 3426564A DE 3426564 A1 DE3426564 A1 DE 3426564A1
Authority
DE
Germany
Prior art keywords
optionally substituted
alkyl
aryl
hydrogen
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE3426564A
Other languages
German (de)
English (en)
Inventor
Günter Dipl.-Chem. Dr. 5620 Velbert Benz
Gerd Dipl.-Chem. Dr. 4150 Krefeld Fengler
Volker Dr. 5090 Leverkusen Fiedler
Michael Dr. Postcombe Oxon Hammond
Mithat Dipl.-Chem. Dr. Madison Conn. Mardin
Dieter Prof. Dipl.-Chem. Dr. 4712 Werne Mayer
Horst Dipl.-Chem. Dr. Meyer
Ekkehard Dipl.-Chem. Dr. 5600 Wuppertal Niemers
Elisabeth Dr. Perzborn
Friedel Dr. 5600 Wuppertal Seuter
William Dr. Windsor Berks. Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE3426564A priority Critical patent/DE3426564A1/de
Priority to EP85108578A priority patent/EP0174458A1/fr
Priority to AU44773/85A priority patent/AU4477385A/en
Priority to IL75824A priority patent/IL75824A0/xx
Priority to ZA855425A priority patent/ZA855425B/xx
Priority to JP60158501A priority patent/JPS6144883A/ja
Publication of DE3426564A1 publication Critical patent/DE3426564A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE3426564A 1984-07-19 1984-07-19 Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind Withdrawn DE3426564A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE3426564A DE3426564A1 (de) 1984-07-19 1984-07-19 Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind
EP85108578A EP0174458A1 (fr) 1984-07-19 1985-07-10 Application des 4H-1,4 benzothiazines à la prophylaxie et la thérapie des maladies des voies respiratoires, des inflammations, des rhumatismes, des maladies thromboemboliques, des ischémies et infarctus, des troubles du rythme cardiaque, artérioscléroses et dermatoses; médicaments ayant cet effet ainsi que les composés réactifs entrant dans la composition de ces médicaments
AU44773/85A AU4477385A (en) 1984-07-19 1985-07-10 4h-1,4-benzothiazines as inhibitors/stimulators of enzymatic reactions
IL75824A IL75824A0 (en) 1984-07-19 1985-07-16 Pharmaceutical compositions containing 4h-1,4-benzothiazines,their preparation and certain such novel compounds
ZA855425A ZA855425B (en) 1984-07-19 1985-07-18 Use of 4h-1,4 benzothiazines for the prophylaxis and therapy of disorders of the respiratory tract,inflammations/rheumatism,thromboembolic disorders,ischaemias and infarcts,cardiac arrhythmias,arteriosclerosis and dermatoses,medicaments for this purpose,and active compounds contained in these medicaments
JP60158501A JPS6144883A (ja) 1984-07-19 1985-07-19 ４ｈ−１，４−ベンゾチアジン類の用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3426564A DE3426564A1 (de) 1984-07-19 1984-07-19 Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind

Publications (1)

Publication Number Publication Date
DE3426564A1 true DE3426564A1 (de) 1986-01-30

Family

ID=6241006

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3426564A Withdrawn DE3426564A1 (de) 1984-07-19 1984-07-19 Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind

Country Status (6)

Country Link
EP (1) EP0174458A1 (fr)
JP (1) JPS6144883A (fr)
AU (1) AU4477385A (fr)
DE (1) DE3426564A1 (fr)
IL (1) IL75824A0 (fr)
ZA (1) ZA855425B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658737B2 (en) * 1992-05-25 1995-04-27 Adir Et Compagnie New heterocyclic compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
WO1999021560A1 (fr) * 1997-10-27 1999-05-06 Howard University Derives de 3-carboylkoxy-2,3-dihydro-1h-phenothiazin-4[10h]-one

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX159669A (es) * 1983-12-12 1989-08-02 Ciba Geigy Ag Procedimiento para la preparacion de derivados de acilamida
DE4305080A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Verfahren zur Herstellung von Azaphenothiazinen
US6448246B1 (en) * 1999-05-25 2002-09-10 Neurogen Corporation Substituted 4H-1,4-benzothiazine-2-carboxamide: GABA brain receptor ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO832663L (no) * 1982-08-04 1984-02-06 Bayer Ag 4h-1,4-benzothiazin-derivat, fremgangsmaate til deres fremstilling og deres anvendelse som laegemiddel, fortilsetningsstoffer og konserveringsmiddel
DE3229122A1 (de) * 1982-08-04 1984-02-09 Bayer Ag, 5090 Leverkusen Anellierte 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3229121A1 (de) * 1982-08-04 1984-02-09 Bayer Ag, 5090 Leverkusen 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658737B2 (en) * 1992-05-25 1995-04-27 Adir Et Compagnie New heterocyclic compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
WO1999021560A1 (fr) * 1997-10-27 1999-05-06 Howard University Derives de 3-carboylkoxy-2,3-dihydro-1h-phenothiazin-4[10h]-one
US5994349A (en) * 1997-10-27 1999-11-30 Howard University 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives
EP1027055A4 (fr) * 1997-10-27 2001-12-05 Univ Howard Derives de 3-carboylkoxy-2,3-dihydro-1h-phenothiazin-4(10h]-one

Also Published As

Publication number Publication date
IL75824A0 (en) 1985-11-29
JPS6144883A (ja) 1986-03-04
AU4477385A (en) 1986-01-23
ZA855425B (en) 1986-02-26
EP0174458A1 (fr) 1986-03-19

Similar Documents

Publication Publication Date Title
EP0261539B1 (fr) Phénylsulfonamides substitués
EP1198453B1 (fr) Derives de n-(indolcarbonyl-)piperazine
DE3617183A1 (de) Substituierte benzylether
CH655110A5 (de) Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
EP0183159A2 (fr) 1-Hétéroaryl-4-aryl-pyrazolin-5-ones pour application en tant que médicaments
EP0185964B1 (fr) Amides d'acide dihydropyridine-carboxylique, procédé pour leur préparation et leur utilisation dans des médicaments
JP2564509B2 (ja) 新規化合物およびそれらの製造方法
EP0161599A2 (fr) Dérivés de benzazépine, médicaments contenant les composés et procédé pour leur préparation
DE69736130T2 (de) Pharmazeutische produkte zur heilung und vorbeugung von krankheiten, die aus der beschädigung der vaskulären endothelzellen hervorgehen
CH640227A5 (de) Aminoalkoxyphenyl-derivate.
DE3426564A1 (de) Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind
DE3873167T2 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
EP1228041B1 (fr) Derives indoliques et leur utilisation comme ligands 5ht2a
DE3049959C2 (fr)
DE4025818A1 (de) Phenylsulfonamid substituierte pyridinalken- und -aminooxyalkancarbonsaeure-derivate
DE69124534T2 (de) Katecholderivate, deren physiologisch unbedenkliche Salze, Ester und deren Verwendung bei der Behandlung von durch Lipidperoxidation verursachten Gewebeschäden
DE2546319C2 (de) Cyclohexylphenyl-Derivate, Verfahren zu deren Herstellung und diese enthaltende Mittel
DD201890A5 (de) Verfahren zur herstellung neuartiger chinolonverbindungen
EP0442348B1 (fr) Composés d'imidazole, procédé de préparation, médicaments à base de ces composés et quelques intermédiaires
DE60113300T2 (de) Piperazinylcarbonylchinoline und isochinoline
EP0125406A2 (fr) Application thérapeutique de dérivés de pyrazolones, les médicaments les contenant et leur procédé de préparation
DE3432062A1 (de) Pyrazoldionderivate und ihre anwendung bei der bekaempfung von krankheiten
DE69008428T2 (de) Leukotrienantagonisten.
DE69107851T2 (de) Phenolische thioetheramide als 5-lipoxygenase-inhibitoren.
HUT60246A (en) Process for producing elastase inhibitior of 2-(heteroaryl)-alikanecarboxylic acid ester type and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
8130 Withdrawal